Its not a medication, and its not approved for human or animal use outside of authorized studies 5-Amino-1MQ is a small-molecule research compound supplied for in-vitro investigation into metabolic and enzymatic signaling pathways, particularly through its activity as an inhibitor of nicotinamide N-methyltransferase (NNMT)
For instance, KRAS mutations in colorectal cancer serve as a negative predictor for response to anti-EGFR therapies [11], while amplification of HER2 in gastric cancer led to the approval of trastuzumab, one of the first targeted treatments in gastrointestinal (GI) oncology [12, 13]
What best describes your main area(s) of concern
SamperTernent R, Kuo YF, Ray LA, Ottenbacher KJ, Markides KS, Al Snih S
These brand-name drugs are not the same as compounded semaglutide with B12
Because retatrutide is unlicensed, it may only be used lawfully in the UK within an authorised clinical trial (as an Investigational Medicinal Product, or IMP) or under specific MHRA-regulated frameworks for unlicensed medicines
